Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis
- PMID: 32213586
- PMCID: PMC7149499
- DOI: 10.1073/pnas.1918607117
Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis
Abstract
Three-dimensional (3D) cell culture is well documented to regain intrinsic metabolic properties and to better mimic the in vivo situation than two-dimensional (2D) cell culture. Particularly, proline metabolism is critical for tumorigenesis since pyrroline-5-carboxylate (P5C) reductase (PYCR/P5CR) is highly expressed in various tumors and its enzymatic activity is essential for in vitro 3D tumor cell growth and in vivo tumorigenesis. PYCR converts the P5C intermediate to proline as a biosynthesis pathway, whereas proline dehydrogenase (PRODH) breaks down proline to P5C as a degradation pathway. Intriguingly, expressions of proline biosynthesis PYCR gene and proline degradation PRODH gene are up-regulated directly by c-Myc oncoprotein and p53 tumor suppressor, respectively, suggesting that the proline-P5C metabolic axis is a key checkpoint for tumor cell growth. Here, we report a metabolic reprogramming of 3D tumor cell growth by oncogenic Kaposi's sarcoma-associated herpesvirus (KSHV), an etiological agent of Kaposi's sarcoma and primary effusion lymphoma. Metabolomic analyses revealed that KSHV infection increased nonessential amino acid metabolites, specifically proline, in 3D culture, not in 2D culture. Strikingly, the KSHV K1 oncoprotein interacted with and activated PYCR enzyme, increasing intracellular proline concentration. Consequently, the K1-PYCR interaction promoted tumor cell growth in 3D spheroid culture and tumorigenesis in nude mice. In contrast, depletion of PYCR expression markedly abrogated K1-induced tumor cell growth in 3D culture, not in 2D culture. This study demonstrates that an increase of proline biosynthesis induced by K1-PYCR interaction is critical for KSHV-mediated transformation in in vitro 3D culture condition and in vivo tumorigenesis.
Keywords: K1; Kaposi's sarcoma-associated herpesvirus (KSHV); cancer metabolism; proline metabolism; pyrroline-5-carboxylate reductase (PYCR).
Conflict of interest statement
Competing interest statement: J.U.J. is a scientific advisor of Vaccine Stabilization Institute, a California corporation.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7149499/bin/pnas.1918607117fig01.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7149499/bin/pnas.1918607117fig02.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7149499/bin/pnas.1918607117fig03.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7149499/bin/pnas.1918607117fig04.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7149499/bin/pnas.1918607117fig05.gif)
![Fig. 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7149499/bin/pnas.1918607117fig06.gif)
Similar articles
-
Isozymes of P5C reductase (PYCR) in human diseases: focus on cancer.Amino Acids. 2021 Dec;53(12):1835-1840. doi: 10.1007/s00726-021-03048-x. Epub 2021 Jul 22. Amino Acids. 2021. PMID: 34291342 Review.
-
PYCR, a key enzyme in proline metabolism, functions in tumorigenesis.Amino Acids. 2021 Dec;53(12):1841-1850. doi: 10.1007/s00726-021-03047-y. Epub 2021 Jul 17. Amino Acids. 2021. PMID: 34273023 Review.
-
Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.J Virol. 2019 Feb 5;93(4):e01599-18. doi: 10.1128/JVI.01599-18. Print 2019 Feb 15. J Virol. 2019. PMID: 30463977 Free PMC article.
-
The Proline Cycle As a Potential Cancer Therapy Target.Biochemistry. 2018 Jun 26;57(25):3433-3444. doi: 10.1021/acs.biochem.8b00215. Epub 2018 Apr 23. Biochemistry. 2018. PMID: 29648801 Free PMC article.
-
Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC.Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):8983-8. doi: 10.1073/pnas.1203244109. Epub 2012 May 21. Proc Natl Acad Sci U S A. 2012. PMID: 22615405 Free PMC article.
Cited by
-
An Update on the Metabolic Landscape of Oncogenic Viruses.Cancers (Basel). 2022 Nov 23;14(23):5742. doi: 10.3390/cancers14235742. Cancers (Basel). 2022. PMID: 36497226 Free PMC article. Review.
-
Metabolomic and transcriptomic studies of improvements in myocardial infarction due to Pycr1 deletion.J Cell Mol Med. 2023 Jan;27(1):89-100. doi: 10.1111/jcmm.17637. Epub 2022 Dec 10. J Cell Mol Med. 2023. PMID: 36495058 Free PMC article.
-
Low-dose radiation exaggerates HFD-induced metabolic dysfunction by gut microbiota through PA-PYCR1 axis.Commun Biol. 2022 Sep 10;5(1):945. doi: 10.1038/s42003-022-03929-1. Commun Biol. 2022. PMID: 36088469 Free PMC article.
-
Herpesvirus-induced spermidine synthesis and eIF5A hypusination for viral episomal maintenance.Cell Rep. 2022 Aug 16;40(7):111234. doi: 10.1016/j.celrep.2022.111234. Cell Rep. 2022. PMID: 35977517 Free PMC article.
-
Polyamine biosynthesis and eIF5A hypusination are modulated by the DNA tumor virus KSHV and promote KSHV viral infection.PLoS Pathog. 2022 Apr 29;18(4):e1010503. doi: 10.1371/journal.ppat.1010503. eCollection 2022 Apr. PLoS Pathog. 2022. PMID: 35486659 Free PMC article.
References
-
- Pampaloni F., Reynaud E. G., Stelzer E. H., The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 8, 839–845 (2007). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA197153/CA/NCI NIH HHS/United States
- R21 AI129496/AI/NIAID NIH HHS/United States
- R01 AI116585/AI/NIAID NIH HHS/United States
- R21 DE027888/DE/NIDCR NIH HHS/United States
- R01 CA221521/CA/NCI NIH HHS/United States
- R01 DE025465/DE/NIDCR NIH HHS/United States
- R01 AI140718/AI/NIAID NIH HHS/United States
- R21 AR074763/AR/NIAMS NIH HHS/United States
- R01 DE023926/DE/NIDCR NIH HHS/United States
- R01 AI073099/AI/NIAID NIH HHS/United States
- R01 CA134241/CA/NCI NIH HHS/United States
- R35 CA200422/CA/NCI NIH HHS/United States
- R01 EB021857/EB/NIBIB NIH HHS/United States
- R01 DE028521/DE/NIDCR NIH HHS/United States
- R35 DE027556/DE/NIDCR NIH HHS/United States
- R01 AI140705/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous